Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial folic acid metabolism involves a series of enzymes that synthesize and modify folate derivatives, which are essential for one-carbon transfer reactions in nucleotide and amino acid biosynthesis. The pathway is critical for bacterial growth and survival, making its enzymes important targets for antibiotics. Key enzymes include dihydrofolate reductase (DHFR), dihydropteroate synthase (DHPS), and thymidylate synthase (TYMS). Inhibition of these enzymes disrupts nucleotide and amino acid synthesis, leading to impaired cell division or death. Resistance can arise through mutations or acquisition of alternative enzyme variants.
Inhibition of bacterial folic acid metabolism
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial Folic Acid Metabolism Enzyme.